Loading...
Artivion, Inc.
AORT•NYSE
Healthcare
Medical - Devices
$31.81
$-0.34(-1.06%)
Artivion, Inc. (AORT) Financial Performance & Statements
Review Artivion, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
9.75%
↑ 9.75%
Operating Income Growth
577.01%
↑ 577.01%
Net Income Growth
56.47%
↑ 56.47%
Operating Cash Flow Growth
18.12%
↑ 18.12%
Operating Margin
4.03%
↑ 4.03%
Gross Margin
63.94%
↑ 63.94%
Net Profit Margin
-5.49%
↓ 5.49%
ROE
-7.31%
↓ 7.31%
ROIC
2.12%
↑ 2.12%
Artivion, Inc. (AORT) Financial Statements
Explore quarterly and annual reports for Artivion, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $97.31M | $95.78M | $98.02M | $97.43M |
| Cost of Revenue | $35.81M | $34.77M | $38.65M | $38.35M |
| Gross Profit | $61.50M | $61.009M | $59.37M | $59.08M |
| Gross Profit Ratio | $0.63 | $0.64 | $0.61 | $0.61 |
| R&D Expenses | $7.40M | $6.61M | $7.50M | $6.95M |
| SG&A Expenses | $51.43M | $50.02M | $43.61M | $26.82M |
| Operating Expenses | $58.83M | $56.62M | $51.11M | $33.77M |
| Total Costs & Expenses | $94.64M | $91.39M | $89.76M | $72.12M |
| Interest Income | $374000.00 | $366000.00 | $353000.00 | $374000.00 |
| Interest Expense | $9.74M | $8.40M | $8.30M | $7.83M |
| Depreciation & Amortization | $6.29M | $6.11M | $5.89M | $5.91M |
| EBITDA | -$565000.00 | $13.25M | $14.20M | $13.77M |
| EBITDA Ratio | -$0.006 | $0.14 | $0.14 | $0.14 |
| Operating Income | $2.67M | $4.39M | $8.26M | $25.31M |
| Operating Income Ratio | $0.03 | $0.05 | $0.08 | $0.26 |
| Other Income/Expenses (Net) | -$19.27M | -$5.65M | -$8.93M | -$12.53M |
| Income Before Tax | -$16.60M | -$1.27M | -$2.43M | $12.78M |
| Income Before Tax Ratio | -$0.17 | -$0.01 | -$0.02 | $0.13 |
| Income Tax Expense | -$119000.00 | $1.02M | -$306000.00 | $5.25M |
| Net Income | -$16.48M | -$2.29M | -$2.12M | $7.53M |
| Net Income Ratio | -$0.17 | -$0.02 | -$0.02 | $0.08 |
| EPS | -$0.39 | -$0.05 | -$0.05 | $0.18 |
| Diluted EPS | -$0.39 | -$0.05 | -$0.05 | $0.18 |
| Weighted Avg Shares Outstanding | $41.88M | $41.84M | $41.68M | $41.29M |
| Weighted Avg Shares Outstanding (Diluted) | $41.88M | $41.84M | $41.68M | $47.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan